PULS
VC Fund
Saint Charles, United States
PULS is a VC fund in Saint Charles focused on Biopharma and Health Care. PULS is the only company worldwide focused entirely on the development and production of DIN rail power supplies. We concentrate our engineering knowledge, resources and energy on one goal: To be the best in this technology. As a result of this focus, we set standards in terms of efficiency and quality that delight our customers.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries PULS invests in
Stages PULS invests in
Countries PULS invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bernhard Erdl
Founder & CEO
|
Founder & CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Adenovir Pharma
|
Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.Adenovir Pharma was founded by researchers at the department of Virology, Umeå University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma islocated in Helsingborg Sweden in one of Europe’s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of Umeå, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). | $787K / Jun 15, 2010 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does PULS invest in?
PULS invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact PULS?
Public channels for PULS include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at PULS?
The team at PULS includes Bernhard Erdl (Founder & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
